BUXORO VILOYATIDA COVID-19 KASALLIGINI TARQALISHIDA BEMORLAR GENDER XUSUSIYATLARINING O’RNI.
Keywords:
Kalit so’zlar: COVID-19, Gender xususiyatlar, gender guruhlar.Abstract
Annotatsiya: Ushbu maqolada COVID-19 kasalligining tarqalishida
bemorlarning gender xususiyatlarining o’rni muhokama qilinadi. O’tkazilgan
tadqiqodlar davomida qaysi jins vakillarida COVID-19 kasalligidan kasallanish
darajasi yuqoriroqligi to’g’risidagi ma’lumotlar tahlil qilinadi.
References
References:
1. WHO. Weekly epidemiological update on COVID-19 — 25 May 2021. URL:
https://www.who.int/publications/m/item/ weekly-epidemiological-update-on-
covid-19---25-may-2021.
2. Iba T., Connors J.M., Levy J.H. The coagulopathy, endotheliopathy, and vasculitis
of COVID-19. Inflamm Res 2020; 69(12): 1181–1189,
https://doi.org/10.1007/s00011-020-01401-6.
3. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z.,
Xiong Y., Zhao Y., Li Y., Wang X., Peng Z. Clinical characteristics of 138
hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan,
China. JAMA 2020; 323(11): 1061–1069, https://doi. org/10.1001/jama.2020.1585.
4. Wu Z., McGoogan J.M. Characteristics of and important lessons from the
coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of
72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA
2020; 323(13): 1239–1242, https://doi.org/10.1001/ jama.2020.2648.
5. Tsatsakis A., Calina D., Falzone L., Petrakis D., Mitrut R., Siokas V., Pennisi M.,
Lanza G., Libra M., Doukas S.G., Doukas P.G., Kavali L., Bukhari A., Gadiparthi
C., Vageli D.P., Kofteridis D.P., Spandidos D.A., Paoliello M.M.B., Aschner M.,
Docea A.O. SARS-CoV-2 pathophysiology and its clinical implications: an
integrative overview of the pharmacotherapeutic management of COVID-19. Food
Chem Toxicol 2020; 146: 111769, https://doi.org/10.1016/j. fct.2020.111769.
6. Pagliaro P. Is macrophages heterogeneity important in determining COVID-19
lethality? Med Hypotheses 2020; 143: 110073,
https://doi.org/10.1016/j.mehy.2020.110073.
7. Sze S., Pan D., Nevill C.R., Gray L.J., Martin C.A., Nazareth J., Minhas J.S., Divall
P., Khunti K., Abrams K.R., Nellums L.B., Pareek M. Ethnicity and clinical
outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine
2020; 29: 100630, https://doi.org/10.1016/j. eclinm.2020.100630.
8. Zhang J., Wang X., Jia X., Li J., Hu K., Chen G., Wei J., Gong Z., Zhou C., Yu H.,
Yu M., Lei H., Cheng F., Zhang B., Xu Y., Wang G., Dong W. Risk factors for
disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan,
China. Clin Microbiol Infect 2020; 26(6): 767–772, https://doi.
org/10.1016/j.cmi.2020.04.012.
9. Liu Y., Mao B., Liang S., Yang J.W., Lu H.W., Chai Y.H., Wang L., Zhang L., Li
Q.H., Zhao L., He Y., Gu X.L., Ji X.B., Li L., Jie Z.J., Li Q., Li X.Y., Lu H.Z., Zhang W.H., Song Y.L., Qu J.M., Xu J.F.; Shanghai Clinical Treatment Experts
Group for COVID-19. Association between age and clinical characteristics and
outcomes of COVID-19. Eur Respir J 2020; 55(5): 2001112,
https://doi.org/10.1183/13993003.01112-2020.
10. Liu X., Lv J., Gan L., Zhang Y., Sun F., Meng B., Jheon A., Yan F., Li B., Xuan
Z., Ma X., Wulasihana M. Comparative analysis of clinical characteristics, imaging
and laboratory findings of different age groups with COVID-19. Indian J Med
Microbiol 2020; 38(1): 87–93, https://doi. org/10.4103/ijmm.ijmm_20_133. 11.
Liu K., Chen Y., Lin R., Han K. Clinical features of COVID-19 in elderly patients:
a comparison with young and middle-aged patients. J Infect 2020; 80(6): e14–e18,
https:// doi.org/10.1016/j.jinf.2020.03.005.
11. Moreno Fernández-Ayala D.J., Navas P., López-Lluch G. Age-related
mitochondrial dysfunction as a key factor in COVID-19 disease. Exp Gerontol
2020; 142: 111147, https:// doi.org/10.1016/j.exger.2020.111147.
12. McGuire P.J. Mitochondrial dysfunction and the aging immune system. Biology
(Basel) 2019; 8(2): 26, https://doi. org/10.3390/biology8020026.
13. López-Lluch G. Mitochondrial activity and dynamics changes regarding
metabolism in ageing and obesity. Mech Ageing Dev 2017; 162: 108–121,
https://doi.org/10.1016/j. mad.2016.12.005.
14. Meng Y., Wu P., Lu W., Liu K., Ma K., Huang L., Cai J., Zhang H., Qin Y., Sun
H., Ding W., Gui L., Wu P. Sexspecific clinical characteristics and prognosis of
Coronavirus Disease-19 infection in Wuhan, China: a retrospective study of 168
severe patients. PLoS Pathog 2020; 16(4): e1008520,
https://doi.org/10.1371/journal.ppat.1008520.
15. Wenham C, Smith J, Morgan R. COVID-19: the gendered impacts of the outbreak.
Lancet. (2020) 395:846–8. doi: 10.1016/S0140-6736(20)30526-2
16. World Health Organization. Taking Sex and Gender into Account in Emerging
Infectious Disease Programme : An Analytical Framework. (2011). Available
online at:
https://apps.who.int/iris/bitstream/handle/10665/207693/9789290615323_eng. pdf
(accessed July 23, 2022).
17. Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex
and gender on COVID-19 outcomes in Europe. Biol Sex Differ. (2020) 19:1–13.
doi: 10.1186/s13293-020-00304-9
18. Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how
biological sex impacts immune responses and COVID-19 outcomes. Nat Rev
Immunol. (2020) 20:442–7. doi: 10.1038/s41577-020-0348-8
19. Kabeer N, Razavi S, van der Meulen Rodgers Y. Feminist economic perspectives
on the COVID-19 pandemic. Fem Econ. (2021) 27:1–29. doi:
10.1080/13545701.2021.187690
